
REGENXBIO to resubmit application for Hunter gene therapy after FDA’s most recent pivot
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQTENSUUs1ZFZTYUlLdFV5Uy10V1VsRzBxaVRKaDROdHh6ejlxb0dqaHhzUFFFYnNONzU5QmRmUEtHUFByTkN3a0JncDczaENCTWlsaTJvaHVJSzFnS1ktcHAtRktQaU1QQnNzUFVsbzZ0WGNZam9ZX3U2UWthWlZITkcwRVVSVGxzTWZ1amR3RzV1dlozQm82Tzk1dnUzcTVUZkVZUE9YeEJkRFdXNnVQWVhhMmJaUQ?oc=5" target="_blank">REGENXBIO to resubmit application for Hunter gene therapy after FDA’s most recent pivot</a>&nbsp;&nbsp;<font color="#6f6f6f">BioSpace</font>
